Mike Matson Analyst PerformanceSenior Analyst at Needham & Company LLCMike Matson is a stock analyst at Needham & Company LLC in the healthcare sector, covering 32 publicly traded companies. Over the past year, Mike Matson has issued 83 stock ratings, including buy and hold recommendations. While full access to Mike Matson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mike Matson's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings409 Last 12 YearsBuy Recommendations77.64% 316 Buy RatingsCompanies Covered32 Unique Companies Ratings Distribution407RatingsDistribution of strong buy, buy, hold, and sell ratings by Mike Matson.RatingPercentageCount Strong Buy4.2%17 ratings Buy73.5%299 ratings Hold21.6%88 ratings Sell0.7%3 ratingsOut of 407 total stock ratings issued by Mike Matson at Needham & Company LLC, the majority (73.5%) have been Buy recommendations, followed by 21.6% Hold, 4.2% Strong Buy, and 0.7% Sell.Best & Worst CallsBest Call0000.0%AMDANov 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%NEONov 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ59.4% of companies on NASDAQ19 companiesNYSE40.6% of companies on NYSE13 companiesMike Matson, an analyst at Needham & Company LLC, currently covers 32 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare32 companies100.0%Mike Matson of Needham & Company LLC specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES26 companies81.3%BIOTECHNOLOGY4 companies12.5%HEALTHCARE PROVIDERS & SERVICES1 company3.1%LIFE SCIENCES TOOLS & SERVICES1 company3.1% About Mike MatsonMike Matson joined Needham & Company in 2013 covering Medical Technologies & Diagnostics. Prior to joining Needham, Mike spent nine years covering the Medical Supplies and Devices industry for Mizuho Securities and Wells Fargo Securities. He previously worked in the medical device industry for Stryker’s Orthopaedics and Endoscopy divisions in marketing and product development. Mike has received multiple awards for stock picking and earnings estimate accuracy. He was ranked first for stock picking in the Health Care Equipment & Supplies sector in the 2017 Thomson Reuters Analyst Awards. He was also ranked tenth in the TipRanks Top Ten Analysts of 2016 (across all sectors), third for earnings estimate accuracy in the Health Care Equipment & Supplies sector in the 2014 Thomson Reuters Analyst Awards, first for earnings estimate accuracy in the Health Care Equipment & Supplies sector in the 2013 Thomson Reuters Analyst Awards, second for stock picking in the Health Care Equipment & Supplies sector in the 2008 Thomson Reuters Analyst Awards, and fourth in the medical device sector for stock picking in the 2007 Wall Street Journal Best on the Street. Mike has a BS in Mechanical Engineering from North Carolina State University with a minor in Economics and a MBA from Duke University’s Fuqua School of Business with a concentration in Health Sector Management. Mike holds a medical device patent (U.S. patent 6,919,914).Follow on LinkedIn Mike Matson's Ratings History at Needham & Company LLC Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsPLSEPulse Biosciences11/17/2026Reiterated Rating$44.65$64.00Buy$0.0000.00% ROIPLSEPulse Biosciences11/6/2026Boost Price Target$53.07$64.00Buy$0.0000.00% ROITMDXTransMedics Group11/6/2026Boost Price Target$87.38$110.00Buy$0.0000.00% ROIVCYTVeracyte11/5/2026Lower Price Target$52.52$46.00Buy$0.0000.00% ROIENOVEnovis11/5/2026Boost Price Target$28.50$38.00Buy$0.0000.00% ROIATRCAtriCure11/4/2026Boost Price Target$60.41$70.00Buy$0.0000.00% ROILIVNLivaNova11/4/2026Boost Price Target$98.11$112.00Buy$0.0000.00% ROIMMSIMerit Medical Systems10/30/2026Boost Price Target$93.39$106.00Buy$0.0000.00% ROISYKStryker10/30/2026Lower Price Target$311.12$359.00Buy$0.0000.00% ROIKIDSOrthoPediatrics10/28/2026Reiterated Rating$23.82$35.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BSXBoston Scientific10/28/2026Lower Price Target$43.27$48.00Buy$0.0000.00% ROIENOVEnovis10/12/2026Lower Price Target$17.72$34.00Buy$0.0000.00% ROINEONeoGenomics10/6/2026Boost Price Target$19.13$22.00Buy$0.0000.00% ROIMMSIMerit Medical Systems9/29/2026Reiterated Rating$87.00$101.00Buy$0.0000.00% ROIMDTMedtronic9/17/2026Reiterated Rating$92.73Buy$0.0000.00% ROIVCYTVeracyte9/15/2026Reiterated Rating$41.21Buy$0.0000.00% ROITMDXTransMedics Group9/11/2026Reiterated Rating$85.04Buy$0.0000.00% ROIATRCAtriCure9/2/2026Boost Price Target$48.92$64.00Buy$0.0000.00% ROIMDTMedtronic8/27/2026Boost Price Target$92.16$114.00Buy$0.0000.00% ROITFXTeleflex8/25/2026Boost Price Target$138.31$170.00Buy$0.0000.00% ROIIMDXInsight Molecular Diagnostics8/18/2026Reiterated Rating$4.27$9.00Buy$0.0000.00% ROIPLSEPulse Biosciences8/17/2026Initiated Coverage$44.54$58.00Buy$0.0000.00% ROIICUIICU Medical8/7/2026Boost Price Target$166.37$187.00Buy$0.0000.00% ROIESTAEstablishment Labs8/6/2026Boost Price Target$79.05$95.00Buy$0.0000.00% ROIKIDSOrthoPediatrics8/5/2026Boost Price Target$20.88$35.00Buy$0.0000.00% ROILIVNLivaNova8/5/2026Boost Price Target$75.34$93.00Buy$0.0000.00% ROITMDXTransMedics Group8/3/2026Lower Price Target$76.51$106.00Buy$0.0000.00% ROIVCYTVeracyte7/31/2026Boost Price Target$59.78$69.00Buy$0.0000.00% ROITFXTeleflex7/31/2026Boost Price Target$132.34$159.00Buy$0.0000.00% ROIMMSIMerit Medical Systems7/31/2026Boost Price Target$83.35$101.00Buy$0.0000.00% ROINEONeoGenomics7/29/2026Boost Price Target$13.40$19.00Buy$0.0000.00% ROIAORTArtivion7/20/2026Reiterated Rating$25.07$44.00Buy$0.0000.00% ROIPSNLPersonalis7/20/2026Downgrade$13.21Hold$0.0000.00% ROIPSNLPersonalis7/17/2026Boost Price Target$15.58$17.00Buy$0.0000.00% ROIBSXBoston Scientific7/8/2026Lower Price Target$45.30$57.00Buy$0.0000.00% ROIMDTMedtronic6/17/2026Reiterated Rating$81.36$101.00Buy$0.0000.00% ROIMDTMedtronic6/3/2026Lower Price Target$77.72$101.00Buy$0.0000.00% ROIVCYTVeracyte6/1/2026Boost Price Target$48.79$57.00Buy$0.0000.00% ROIVCYTVeracyte5/28/2026Reiterated Rating$44.49$48.00Buy$0.0000.00% ROIICUIICU Medical5/27/2026Upgrade$134.97$165.00Buy$0.0000.00% ROIURGENT: If you own a home, please review the map below. (Ad)More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.See the map and get the full details on what this means for youBSXBoston Scientific5/18/2026Reiterated Rating$55.35$77.00Buy$0.0000.00% ROIAORTArtivion5/8/2026Lower Price Target$35.38$44.00Buy$0.0000.00% ROITMDXTransMedics Group5/6/2026Lower Price Target$94.93$142.00Buy$0.0000.00% ROISYKStryker5/1/2026Lower Price Target$314.64$418.00Buy$0.0000.00% ROIMMSIMerit Medical Systems5/1/2026Lower Price Target$68.18$90.00Buy$0.0000.00% ROIBSXBoston Scientific4/23/2026Lower Price Target$64.95$77.00Buy$0.0000.00% ROIAORTArtivion4/20/2026Reiterated Rating$37.79Buy$0.0000.00% ROIAORTArtivion4/7/2026Reiterated Rating$35.00$58.00Buy$0.0000.00% ROIVCYTVeracyte4/1/2026Reiterated Rating$32.21$48.00Buy$0.0000.00% ROIMMSIMerit Medical Systems4/1/2026Reiterated Rating$68.23$101.00Buy$0.0000.00% ROIBSXBoston Scientific3/30/2026Reiterated Rating$69.21$97.00Buy$0.0000.00% ROIMDTMedtronic3/26/2026Reiterated Rating$87.84$120.00Buy$0.0000.00% ROILUCDLucid Diagnostics3/26/2026Reiterated Rating$1.18$3.00Buy$0.0000.00% ROIBSXBoston Scientific3/20/2026Reiterated Rating$70.04$97.00Buy$0.0000.00% ROIMDTMedtronic3/10/2026Reiterated Rating$90.21$120.00Buy$0.0000.00% ROIKIDSOrthoPediatrics2/27/2026Boost Price Target$17.79$30.00Buy$0.0000.00% ROIPSNLPersonalis2/27/2026Boost Price Target$9.03$12.00Buy$0.0000.00% ROIENOVEnovis2/26/2026Boost Price Target$25.39$52.00Buy$0.0000.00% ROITFXTeleflex2/26/2026Boost Price Target$119.19$147.00Buy$0.0000.00% ROIVCYTVeracyte2/26/2026Boost Price Target$35.72$48.00Buy$0.0000.00% ROIMMSIMerit Medical Systems2/25/2026Lower Price Target$82.43$101.00Buy$0.0000.00% ROITMDXTransMedics Group2/25/2026Boost Price Target$137.78$174.00Buy$0.0000.00% ROILIVNLivaNova2/25/2026Boost Price Target$69.98$81.00Buy$0.0000.00% ROIESTAEstablishment Labs2/24/2026Boost Price Target$76.35$86.00Buy$0.0000.00% ROIMDTMedtronic2/17/2026Lower Price Target$96.33$120.00Buy$0.0000.00% ROINEONeoGenomics2/17/2026Boost Price Target$11.44$15.00Buy$0.0000.00% ROIATRCAtriCure2/12/2026Reiterated Rating$32.90$45.00Buy$0.0000.00% ROIZBHZimmer Biomet2/10/2026Reiterated Rating$92.60Hold$0.0000.00% ROIMDTMedtronic2/9/2026Upgrade$102.89$121.00Buy$0.0000.00% ROIBSXBoston Scientific2/5/2026Lower Price Target$75.50$97.00Buy$0.0000.00% ROIAORTArtivion2/2/2026Reiterated Rating$41.12$58.00Buy$0.0000.00% ROISYKStryker1/30/2026Boost Price Target$354.39$454.00Buy$0.0000.00% ROICNMDCONMED1/29/2026Reiterated Rating$38.59Hold$0.0000.00% ROITFXTeleflex1/27/2026Upgrade$104.13$138.00Buy$0.0000.00% ROIPENPenumbra1/16/2026Downgrade$350.53Hold$0.0000.00% ROIBSXBoston Scientific1/15/2026Reiterated Rating$90.00Buy$0.0000.00% ROINEONeoGenomics1/12/2026Reiterated Rating$12.57$14.00Buy$0.0000.00% ROIESTAEstablishment Labs1/12/2026Reiterated Rating$66.13$84.00Buy$0.0000.00% ROIMMSIMerit Medical Systems1/9/2026Reiterated Rating$93.18$108.00Buy$0.0000.00% ROIPENPenumbra12/17/2025Boost Price Target$308.27$388.00Buy$0.0000.00% ROIHAEHaemonetics12/15/2025Downgrade$83.46Hold$0.0000.00% ROIESTAEstablishment Labs12/10/2025Boost Price Target$71.01$84.00Buy$0.0000.00% ROITMDXTransMedics Group12/8/2025Boost Price Target$136.51$166.00Buy$0.0000.00% ROISYKStryker11/14/2025Reiterated Rating$372.93$448.00Buy$000.0000.00% ROILUCDLucid Diagnostics11/13/2025Reiterated Rating$1.11$3.00Buy$0.0000.00% ROIHAEHaemonetics11/7/2025Boost Price Target$67.66$78.00Buy$000.0000.00% ROIAORTArtivion11/7/2025Boost Price Target$47.54$58.00Buy$00.0000.00% ROIESTAEstablishment Labs11/6/2025Boost Price Target$60.51$70.00Buy$00.0000.00% ROIPSNLPersonalis11/5/2025Boost Price Target$8.73$10.00Buy$00.0000.00% ROIVCYTVeracyte11/5/2025Boost Price Target$36.12$44.00Buy$00.0000.00% ROIELON + YOU + DECEMBER 8TH (Ad)Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.Watch the free Masterclass now to learn what happens on December 8thHOLXHologic11/4/2025Reiterated Rating$74.06Hold$0.0000.00% ROIMMSIMerit Medical Systems10/31/2025Reiterated Rating$83.04$108.00Buy$00.0000.00% ROITMDXTransMedics Group10/30/2025Reiterated Rating$134.32Buy$00.0000.00% ROIKIDSOrthoPediatrics10/29/2025Lower Price Target$16.91$26.00Buy$00.0000.00% ROIPENPenumbra10/27/2025Reiterated Rating$253.61$326.00Buy$000.0000.00% ROITMDXTransMedics Group10/23/2025Upgrade$119.54$148.00Buy$00.0000.00% ROIHOLXHologic10/21/2025Reiterated Rating$74.17Hold$0.0000.00% ROIBSXBoston Scientific10/17/2025Reiterated Rating$98.54$121.00Buy$00.0000.00% ROIINMDInMode10/10/2025Reiterated Rating$15.89Hold$00.0000.00% ROIPENPenumbra10/8/2025Set Price Target$249.05$326.00Buy$000.0000.00% ROIPENPenumbra10/8/2025Upgrade$258.92$326.00Buy$000.0000.00% ROIBSXBoston Scientific10/1/2025Reiterated Rating$97.55$121.00Buy$00.0000.00% ROIBSXBoston Scientific9/19/2025Reiterated Rating$98.29$121.00Buy$00.0000.00% ROIBSXBoston Scientific9/11/2025Reiterated Rating$105.32$121.00Buy$00.0000.00% ROILIVNLivaNova9/3/2025Reiterated Rating$56.92$64.00Buy$00.0000.00% ROINEONeoGenomics8/29/2025Boost Price Target$8.87$14.00Buy$00.0000.00% ROITMDXTransMedics Group8/25/2025Reiterated Rating$117.15Hold$00.0000.00% ROIAORTArtivion8/22/2025Boost Price Target$43.12$50.00Buy$00.0000.00% ROIMDTMedtronic8/14/2025Reiterated Rating$92.04Hold$00.0000.00% ROILUCDLucid Diagnostics8/13/2025Reiterated Rating$0.99$3.00Buy$0.0000.00% ROIAORTArtivion8/8/2025Boost Price Target$32.78$45.00Buy$00.0000.00% ROIENOVEnovis8/7/2025Lower Price Target$28.45$49.00Buy$00.0000.00% ROIHAEHaemonetics8/7/2025Reiterated Rating$56.94$68.00Buy$00.0000.00% ROISYKStryker8/1/2025Boost Price Target$393.37$448.00Buy$000.0000.00% ROIINMDInMode7/30/2025Reiterated Rating$14.09Hold$00.0000.00% ROIATRCAtriCure7/30/2025Boost Price Target$31.73$45.00Buy$00.0000.00% ROINEONeoGenomics7/29/2025Lower Price Target$5.25$8.00Buy$00.0000.00% ROIMMSIMerit Medical Systems7/18/2025Reiterated Rating$84.54$108.00Buy$00.0000.00% ROILUCDLucid Diagnostics7/16/2025Reiterated Rating$1.19$3.00Buy$0.0000.00% ROIMMSIMerit Medical Systems7/8/2025Reiterated Rating$91.12$108.00Buy$00.0000.00% ROITMDXTransMedics Group6/17/2025Reiterated Rating$141.96Hold$00.0000.00% ROIESTAEstablishment Labs6/13/2025Reiterated Rating$37.12$48.00Buy$00.0000.00% ROICNMDCONMED6/12/2025Downgrade$57.02$61.00Hold$00.0000.00% ROIMDTMedtronic6/6/2025Reiterated Rating$86.92Hold$00.0000.00% ROITMDXTransMedics Group6/3/2025Reiterated Rating$123.94Hold$00.0000.00% ROIBSXBoston Scientific5/28/2025Reiterated Rating$105.21$115.00Buy$00.0000.00% ROIHOLXHologic5/27/2025Reiterated Rating$62.14Hold$0.0000.00% ROIINGNInogen5/22/2025Upgrade$5.96$12.00Moderate Buy$0.0000.00% ROIMDTMedtronic5/19/2025Reiterated Rating$86.41Hold$00.0000.00% ROIMMSIMerit Medical Systems5/15/2025Boost Price Target$97.77$108.00Buy$00.0000.00% ROIESTAEstablishment Labs5/14/2025Upgrade$34.96$48.00Buy$00.0000.00% ROILUCDLucid Diagnostics5/14/2025Reiterated Rating$1.24$3.00Buy$0.0000.00% ROILIVNLivaNova5/13/2025Reiterated Rating$45.23$64.00Buy$00.0000.00% ROIENOVEnovis5/9/2025Lower Price Target$33.11$57.00Buy$00.0000.00% ROIKIDSOrthoPediatrics5/8/2025Reiterated Rating$22.21$42.00Buy$00.0000.00% ROIVCYTVeracyte5/8/2025Lower Price Target$30.80$41.00Buy$00.0000.00% ROIHAEHaemonetics5/8/2025Lower Price Target$68.55$84.00Buy$00.0000.00% ROIAORTArtivion5/6/2025Reiterated Rating$23.69$32.00Buy$00.0000.00% ROIHOLXHologic5/2/2025Reiterated Rating$57.28Hold$0.0000.00% ROICNMDCONMED5/1/2025Lower Price Target$48.91$61.00Buy$00.0000.00% ROIGet your evenings back (Ad)The Instant Scanner delivers the night's qualifying setups with exact buy prices and defined exits, in minutes. No hours of flipping through charts, no second-guessing patterns. It's built for traders who want the result without the ritual: a short list and your evening back. Black Friday price is $7 versus the regular $247. One payment covers a full year, with no re-bills.Get the Instant Scanner for $7 in the Black Friday sale.ATRCAtriCure4/30/2025Lower Price Target$34.65$44.00Buy$00.0000.00% ROINEONeoGenomics4/29/2025Lower Price Target$6.69$8.50Buy$0.0000.00% ROIINMDInMode4/28/2025Reiterated Rating$14.32Hold$00.0000.00% ROIMMSIMerit Medical Systems4/25/2025Lower Price Target$94.67$100.00Buy$00.0000.00% ROIBSXBoston Scientific4/24/2025Boost Price Target$101.56$115.00Buy$00.0000.00% ROITMDXTransMedics Group4/23/2025Reiterated Rating$91.21Hold$000.0000.00% ROIBSXBoston Scientific4/16/2025Upgrade$94.19$113.00Buy$00.0000.00% ROIESTAEstablishment Labs4/14/2025Initiated Coverage$30.34Hold$00.0000.00% ROILUCDLucid Diagnostics4/11/2025Reiterated Rating$1.25$3.00Buy$0.0000.00% ROIMASIMasimo4/10/2025Reiterated Rating$164.57Hold$000.0000.00% ROIPSNLPersonalis4/10/2025Reiterated Rating$3.38$7.00Buy$0.0000.00% ROIINGNInogen4/9/2025Reiterated Rating$6.59Hold$0.0000.00% ROIMMSIMerit Medical Systems4/9/2025Reiterated Rating$88.48$116.00Buy$00.0000.00% ROIKIDSOrthoPediatrics4/9/2025Reiterated Rating$21.77$42.00Buy$00.0000.00% ROIENOVEnovis4/9/2025Reiterated Rating$30.60$64.00Buy$00.0000.00% ROIINMDInMode4/9/2025Reiterated Rating$14.48Hold$00.0000.00% ROIICUIICU Medical4/8/2025Reiterated Rating$142.25Hold$000.0000.00% ROISTESTERIS4/7/2025Reiterated Rating$212.69Hold$000.0000.00% ROIENOVEnovis4/2/2025Reiterated Rating$35.88$64.00Buy$00.0000.00% ROIATRCAtriCure3/27/2025Reiterated Rating$33.62$51.00Buy$00.0000.00% ROITMDXTransMedics Group3/26/2025Reiterated Rating$70.79Hold$000.0000.00% ROILUCDLucid Diagnostics3/24/2025Boost Price Target$1.54$3.00Buy$0.0000.00% ROIATRCAtriCure3/21/2025Reiterated Rating$34.82$51.00Buy$00.0000.00% ROISYKStryker3/21/2025Reiterated Rating$373.69$442.00Buy$000.0000.00% ROIHAEHaemonetics3/18/2025Lower Price Target$64.84$104.00Buy$00.0000.00% ROILIVNLivaNova3/17/2025Reiterated Rating$39.24$64.00Buy$00.0000.00% ROITFXTeleflex3/12/2025Reiterated Rating$139.25Hold$000.0000.00% ROIKIDSOrthoPediatrics3/5/2025Reiterated Rating$22.89$42.00Buy$00.0000.00% ROIBSXBoston Scientific3/3/2025Reiterated Rating$104.59Hold$00.0000.00% ROIPSNLPersonalis2/28/2025Lower Price Target$4.24$7.00Buy$0.0000.00% ROIENOVEnovis2/27/2025Lower Price Target$40.03$64.00Buy$00.0000.00% ROIINGNInogen2/26/2025Reiterated Rating$9.52Hold$0.0000.00% ROIMMSIMerit Medical Systems2/26/2025Lower Price Target$102.05$116.00Buy$00.0000.00% ROIMASIMasimo2/26/2025Reiterated Rating$169.54Hold$000.0000.00% ROILIVNLivaNova2/26/2025Lower Price Target$41.70$64.00Buy$00.0000.00% ROIAORTArtivion2/25/2025Lower Price Target$27.90$32.00Buy$00.0000.00% ROIVCYTVeracyte2/25/2025Reiterated Rating$39.36$51.00Buy$00.0000.00% ROIPENPenumbra2/19/2025Reiterated Rating$270.99Hold$000.0000.00% ROIMDTMedtronic2/19/2025Reiterated Rating$86.05Hold$00.0000.00% ROINEONeoGenomics2/19/2025Lower Price Target$12.40$18.00Buy$00.0000.00% ROIATRCAtriCure2/13/2025Reiterated Rating$42.36$51.00Buy$00.0000.00% ROIMDTMedtronic2/12/2025Reiterated Rating$91.18Hold$000.0000.00% ROIZBHZimmer Biomet2/7/2025Reiterated Rating$102.84Hold$00.0000.00% ROIHAEHaemonetics2/7/2025Lower Price Target$62.95$108.00Buy$00.0000.00% ROICNMDCONMED2/6/2025Lower Price Target$74.35$91.00Buy$00.0000.00% ROIBSXBoston Scientific2/6/2025Reiterated Rating$104.95Hold$00.0000.00% ROITMDXTransMedics Group2/5/2025Reiterated Rating$72.14Hold$000.0000.00% ROIINMDInMode2/4/2025Reiterated Rating$16.80Hold$00.0000.00% ROIHOLXHologic2/3/2025Downgrade$72.14$90.00Hold$00.0000.00% ROIRMDResMed1/31/2025Reiterated Rating$257.63Hold$000.0000.00% ROIA Bill Would Reprice America's Gold at Market Value (Ad)The US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,000 today, leaving a trillion-dollar gap on the books. A bill now moving through Congress would require the Treasury to reprice America's gold at true market value. Companion legislation would trigger the first full audit of US reserves in over 65 years.Request your free 2026 Gold Guide to see what repricing could mean for you.INGNInogen1/30/2025Reiterated Rating$12.53Hold$0.0000.00% ROIVCYTVeracyte1/29/2025Boost Price Target$43.67$51.00Buy$00.0000.00% ROISYKStryker1/29/2025Reiterated Rating$394.92$442.00Buy$000.0000.00% ROIMMSIMerit Medical Systems1/29/2025Boost Price Target$109.03$122.00Buy$00.0000.00% ROIZBHZimmer Biomet1/29/2025Reiterated Rating$112.06Hold$00.0000.00% ROIFNAParagon 281/29/2025Reiterated Rating$13.03$13.00Hold$0.0000.00% ROILIVNLivaNova1/28/2025Reiterated Rating$49.53$75.00Buy$00.0000.00% ROIAORTArtivion1/28/2025Reiterated Rating$30.82$34.00Buy$00.0000.00% ROIATRCAtriCure1/22/2025Boost Price Target$39.63$51.00Buy$00.0000.00% ROIMASIMasimo1/22/2025Reiterated Rating$176.07Hold$000.0000.00% ROIMASIMasimo1/16/2025Reiterated Rating$170.69Hold$000.0000.00% ROIKIDSOrthoPediatrics1/14/2025Reiterated Rating$25.00$42.00Buy$00.0000.00% ROIINGNInogen1/14/2025Reiterated Rating$10.33Hold$0.0000.00% ROIMMSIMerit Medical Systems1/14/2025Reiterated Rating$95.64$109.00Buy$00.0000.00% ROIHOLXHologic1/13/2025Reiterated Rating$71.70$90.00Buy$00.0000.00% ROIFNAParagon 281/13/2025Reiterated Rating$10.80$13.00Buy$0.0000.00% ROIATRCAtriCure1/13/2025Reiterated Rating$33.18$40.00Buy$00.0000.00% ROINEONeoGenomics1/10/2025Reiterated Rating$14.93$19.00Buy$00.0000.00% ROITMDXTransMedics Group12/11/2024Reiterated Rating$68.99Hold$000.0000.00% ROITMDXTransMedics Group12/3/2024Reiterated Rating$85.14Hold$000.0000.00% ROIHAEHaemonetics12/3/2024Reiterated Rating$85.33$112.00Buy$00.0000.00% ROIBSXBoston Scientific11/27/2024Reiterated Rating$90.19Hold$000.0000.00% ROITMDXTransMedics Group11/22/2024Reiterated Rating$79.34$109.00Hold$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist FinancialPiper SandlerBMO Capital MarketsRaymond James FinancialMizuhoStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.